openPR Logo
Press release

Cerebral Cavernous Malformation Market 2019 Outlook & Deep Study of Top Key Players: BioAxone, Recursion Pharmaceuticals Inc, GlaxoSmithKline plc

12-27-2019 11:36 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

Cerebral Cavernous Malformation Market

Cerebral Cavernous Malformation Market

The statistical and numerical data such as facts and figures are represented very neatly in the Global Cerebral Cavernous Malformation Market report by using charts, tables or graphs. To generate finest market research report, marketing management must be aware of the minds of their target markets, their feelings, their preferences, their attitudes, convictions and value systems with a formalised and managerial approach. This market report offers CAGR value fluctuation in percentage during the forecast period of 2019-2026 for the market. The report is an ultimate solution for businesses if they want to stay ahead of the competition in today's fast moving business environment.

Market Analysis:

Global cerebral cavernous malformation market is expected to grow at a steady CAGR in the forecast period of 2019-2026. Special designation from the regulatory authority can and high unmet need of disease is fueling the market growth.

Get Sample Report + All Related Graphs & Charts @

Key Market Players:

Few of the major competitors currently working in the global cerebral cavernous malformation market are BioAxone, Recursion Pharmaceuticals Inc, GlaxoSmithKline plc, Sanofi, Pfizer Inc, Novartis AG, Abbott, Sumitomo Dainippon Pharma Co., Ltd, Teva Pharmaceutical Industries Ltd and others.

Competitive Analysis:

Global cerebral cavernous malformation market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global cerebral cavernous malformation Market for Global, Europe, North America,
Asia-Pacific, South America and Middle East & Africa.

Global Cerebral Cavernous Malformation Market By Type (Familial Cerebral
Cavernous Malformation, Sporadic Cerebral Cavernous Malformation), Treatment (Medication, Surgery), Drugs (Antiepileptic, Pain Management), Route of Administration (Oral, Injectable), End- Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026

Market Definition: Global Cerebral Cavernous Malformation Market

Cerebral cavernous malformation is also known as cavernous angioma is rare genetic disorders characterized by loss function in one of three cerebral cavernous malformations genes which resulting in over-production of Rho kinase in cerebral endothelial cells which eventually leads to benign endothelial cell tumors that cause headache, seizures and neurological deficits such as paralysis.
According to the statistics published by the U.S. Department of Health & Human Services, the prevalence of cerebral cavernous malformation is estimated to be about 0.5 % of the population worldwide. High demand of novel treatment and huge investment on research and development are drivers for market growth

Key Developments in the Market:

• In March 2018, Recursion Pharmaceuticals Inc, received the acceptance of an investigational new drug (IND) application from the FDA for REC-994, a potent, selective superoxide dismutase mimetic for phase I clinical trial in the treatment of cerebral cavernous malformation. This drug has been granted by orphan designation by the FDA for the symptomatic treatment of symptomatic cerebral cavernous malformation also by the EMA for the treatment of familial cerebral cavernous malformation. If trial successful, it will be first ever non-surgical treatment options for patients living with cerebral cavernous malformation throughout the world.

• In February 2016, BioAxone received Fast-Track grant from the NIH Small Business and Innovation Research Program (SBIR) and the National Institute of Neurological Disorders and Stroke (NINDS) for BA-1049, a small molecule kinase inhibitor for the treatment of cerebral cavernous malformations. This grant will allow the company to collaborate with consortium of industry and academic partners to develop the first effective drug to treat cerebral cavernous malformations.

Market Drivers

• Increase in special designation from the regulatory authorities is drive the market
• Huge financial support to the researchers for developing novel intervention is boosting the market growth
• High demand of disease specific novel treatment can also act as a market driver
• Emergence of drugs used in the treatment of complication associated with cerebral cavernous malformation is enhancing the market growth

Market Restraints

• Low healthcare budget in some developing countries is hamper the market growth
• Stringent and hefty regulation is also acting as a challenging factor for the growth of this market

Grab Your Report at an Impressive 30% Discount! Please click here@

Segmentation: Global Cerebral Cavernous Malformation Market

By Type
• Familial Cerebral Cavernous Malformation
• Sporadic Cerebral Cavernous Malformation

By Treatment
• Medication
• Surgery

By Drugs
• Antiepileptic
• Pain Management

By Route of Administration
• Oral
• Injectable

By End Users
• Hospitals
• Homecare
• Specialty Clinics
• Others

By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Others

By Geography

• North America
• South America
• Europe
• Asia-Pacific
• Middle East & Africa

Reasons to Purchase this Report

• Current and future of global cerebral cavernous malformation market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
• Regions/Countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cerebral Cavernous Malformation Market 2019 Outlook & Deep Study of Top Key Players: BioAxone, Recursion Pharmaceuticals Inc, GlaxoSmithKline plc here

News-ID: 1886472 • Views: 162

More Releases from Data Bridge Market Research

Robotic Process Automation (RPA) Market Competitive Outlook: Automation Anywhere …
A new business intelligence report released by Data Bridge Market research with titled "Global Robotic process automation Market" (covering USA, Europe, China, Japan, India, South East Asia and etc) that targets and provides comprehensive market analysis with future prospects to 2026. This rise in the market can be attributed due to rising popularity and attractiveness of enterprise resource planning which is driving the needs of the business to
Digital Assurance Market Competitive Outlook: Atos, Accenture, Capgemini, Cignit …
Data Bridge Market researchhas recently released expansive research on Global Digital Assurance Market with 100+ market data Tables, Pie Chart, Graphs & Figures spread through Pages and easy to understand detailed analysis. The report endows with wide-ranging statistical analysis of the market's continuous developments, capacity, production, production value, cost/profit, supply/demand and import/export. This market report provides best solutions for strategy development and implementation depending on client's needs to extract tangible
Rear E Axle Market Future Outlook | ZF Friedrichshafen AG, Schaeffler AG,Contine …
Front rear E axle market will register the growth rate of 23.50% for the forecast period of 2020 to 2027. Rising usage of E-axle in ICE vehicles is expected to create new opportunity for the market. Growing sales of electric and hybrid vehicles is expected to enhance the market growth. Some of the other factors such as increasing cost of the fuels, strict emissions rules to decrease the vehicle weight
Cognitive Assessment And Training In Healthcare Market Size, Share, Trends and C …
A detailed study of the competitive landscape of the cognitive assessment and training in healthcare market has been given here along with the insights of the companies, financial status, trending developments, mergers & acquisitions and SWOT analysis. This market report also provides comprehensive statistics on important aspects such as growth drivers, challenges and industry prospects. cognitive assessment and training in healthcare report includes a study on the marketing and development

All 5 Releases

More Releases for Cerebral

Cerebral Palsy Therapeutics Clinical Trials & Results
In cerebral palsy, the term cerebral refers to brain and palsy refers to the loss or impairment of motor function. Cerebral palsy is a group of neurological disorders that appear in infancy or early childhood, and permanently affect body movement and muscle coordination. Download the sample report @ It is caused by damage or abnormalities inside the developing brain that disrupt its ability to control movement and maintain posture and balance.
Cerebral Palsy Market Expert Reviews Forecast 2025
Global Cerebral Palsy Market: Snapshot The global cerebral palsy market is picking up steam due to increasing awareness about the condition amongst parents. The market is projected to experience a growth spurt in the coming years as access to medical healthcare improves along with disposable income. The increasing research and development for developing better treatment options for cerebral palsy has also resulted in growing number patients opting for this treatment. Today,
Finding confidence and independence with cerebral palsy
Yemina is an active, fun and smart twelve year old from Canada who loves to read or hang out with friends. She also has cerebral palsy which affects all of her movement and her level of independence. Her mum, Shoshana, explains that Yemina's cerebral palsy makes any activity involving movement a challenge, but particularly those involving hand control. "She has a lot of extra movement through her
Cerebral Vasospasm Market 2023: Comprehensive Research Study
Market Research Future published a research report on “Global Cerebral Vasospasm Market Research Report Forecast to 2023“– Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023. Global Cerebral Vasospasm Market Research Report, by Treatment (triple-H therapy, nimodipine and other), by Route of Administration (oral, intravenous and intra-arterial), by End User (hospitals, clinics and others)- Forecast Till 2023 Market Scenario: Cerebral vasospasm is a condition where blood vesicles becomes narrow due to contraction.
Cerebral Oximeters Market : Global Markets & Advanced Technologies
The fundamental aim of the anesthetic process is maintenance of sufficient amount of oxygen to organs and tissues, especially the brain. Though the dangers to the brain of reduced oxygen delivery and prolonged hypoxia are well documented, the brain is still the least monitored organ in the course of anesthesia. Cerebral oximeters are used to obtain cerebral oxygenation values using continuous, noninvasive near-infrared spectroscopy (NIRS) technology or near-infrared spectroscopy technology. The
Cerebral Palsy - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Cerebral Palsy - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cerebral Palsy - Pipeline Review, H1 2017, provides an overview of the Cerebral Palsy (Central Nervous System) pipeline landscape. Cerebral palsy is a group of disorders that can involve brain and nervous system functions, such as